Skip to main content
. 2013 Aug 9;23(1):1–11. doi: 10.1093/hmg/ddt387

Table 3.

Echocardiographic data for 20-week-old male LmnaH222P/H222P/Erk1−/− mice treated with DMSO or selumetinib

Treatment n Heart rate (beats/ min) LVEDD (mm) LVESD (mm) FS (%)
DMSO 15 500 ± 1 4.5 ± 0.2 3.8 ± 0.2 16.8 ± 1.6
Selumetinib 8 500 ± 1 3.5 ± 0.1*** 2.4 ± 0.1*** 31.3 ± 1.8***

Values are means ± standard errors; ***P < 0.0005 for comparison between DMSO and selumetinib-treated LmnaH222P/H222P/Erk1−/− mice.